B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Fluoxetine

The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.

1,000 PubMed studies analyzed · 542 RCTs · Evidence Score: 73.4

Research Domains

Fluoxetine has been studied across 17 research domains including 🌤️ Mood & Depression, 😴 Sleep, 🧘 Stress & Anxiety, ❤️ Cardiovascular, 🧠 Cognitive. The primary research focus is 🌤️ Mood & Depression with 69% of studies addressing this area.

Loading evidence profile...

This evidence profile for Fluoxetine is generated deterministically from 1,000 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.